AbbVie Receives Positive CHMP Opinion for VENCLYXTO (venetoclax) as a Combination Regimen for Adult Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible...

Mount Carmel Register

Apr 23, 2021

AbbVie Receives Positive CHMP Opinion for VENCLYXTO (venetoclax) as a Combination Regimen for Adult Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Inte…